Physician

Alan S Serure, M.D.

According to 2025 Medicare claims, Alan Serure, M.D. (NPI: 1003962184) practices plastic and reconstructive surgery in the Miami-Miami Beach-Kendall, FL market, with the plurality of this provider's patient population coming from Miami-Dade, FL. This provider's primary affiliated billing organization is ALAN SERURE, MD, PA. (NPI: 1285904482) and primary practice location at 33143-0000.

Serure's data goes back to 2015 and runs through 2024. For example, in 2017, this provider had 15 traditional Medicare patients, billed 34 HCPCS/CPT codes, and received $9,282 in Medicare payments. 2024 Part D data shows 22 prescription claims totaling $374 in drug costs. Open Payments data shows 4 records totaling $189. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have declined steadily, from $3,624 to $374. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	17	39	$11,344
2016	N/R	N/R	N/R
2017	15	34	$9,282
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	33	180	$3,624
2016	18	102	$1,491
2017	32	154	$2,491
2018	34	191	$3,868
2019	37	144	$2,230
2020	19	47	$585
2021	N/R	11	$129
2022	N/R	19	$403
2023	N/R	19	$132
2024	N/R	22	$374

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

No connected Part B code-level records for 2024.

Top 5 Part D drugs in 2024

By total drug costs.

Part D summary data is connected for 2024, but public drug-level costs are not available, so a Top 5 by total drug costs cannot be shown.

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$189	Galderma Laboratories, L.P.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alan S. Serure, M.D.?

Tedicare shows public-source Medicare data for Alan S. Serure, M.D. (NPI 1003962184), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alan S. Serure, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alan S. Serure, M.D.?

Alan S. Serure, M.D. is linked to ALAN SERURE, MD, PA. (billing NPI 1285904482) in the available physician profile data.

Does Alan S. Serure, M.D. have Open Payments data?

Alan S. Serure, M.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.